§ 2004a. Evidence-Based Education and Advertising Fund
(a) The Evidence-Based Education and Advertising Fund is established in the State Treasury as a special fund to be a source of financing for activities relating to fund collection and analysis of information on pharmaceutical marketing activities under 18 V.S.A. §§ 4632 and 4633; for analysis of prescription drug data needed by the Office of the Attorney General for enforcement activities; for the Vermont Prescription Monitoring System established in 18 V.S.A. chapter 84A; for the evidence-based education program established in 18 V.S.A. chapter 91, subchapter 2; for statewide unused prescription drug disposal initiatives; for the prevention of prescription drug misuse, abuse, and diversion; for the Substance Misuse Prevention Oversight and Advisory Council established in 18 V.S.A. § 4803; for treatment of substance use disorder; for exploration of nonpharmacological approaches to pain management; for a hospital antimicrobial program for the purpose of reducing hospital-acquired infections; for the purchase and distribution of fentanyl testing strips; for the purchase and distribution of naloxone to emergency medical services personnel; and for the support of any opioid-antagonist education, training, and distribution program operated by the Department of Health or its agents. Monies deposited into the Fund shall be used for the purposes described in this section.
(b) Into the Fund shall be deposited:
(1) revenue from the manufacturer fee established under section 2004 of this title; and
(2) the proceeds from grants, donations, contributions, taxes, and any other sources of revenue as may be provided by statute, rule, or act of the General Assembly.
(c) The Fund shall be administered pursuant to 32 V.S.A. chapter 7, subchapter 5, except that interest earned on the Fund and any remaining balance shall be retained in the Fund. (Added 2007, No. 80, § 20a; amended 2011, No. 162 (Adj. Sess.), § E.311.1, eff. May 17, 2012; 2013, No. 50, § E.312.2; 2013, No. 95 (Adj. Sess.), § 85, eff. Feb. 25, 2014; 2015, No. 173 (Adj. Sess.), § 13; 2019, No. 72, § E.313.1.)
Structure Vermont Statutes
Chapter 19 - Medical Assistance
§ 1901. Administration of program
§ 1901b. Pharmacy program enrollment
§ 1901d. State Health Care Resources Fund
§ 1901e. Global Commitment Fund
§ 1901f. Medicaid program enrollment and expenditure reports
§ 1901g. Medicaid coverage for home telemonitoring services
§ 1901j. Medicaid reimbursement for long-acting reversible contraceptives
§ 1901k. Medicaid coverage for hearing aids and audiology services
§ 1902. Qualification for medical assistance
§ 1903a. Care management program
§ 1905. Disproportionate share program
§ 1905a. Medicaid reimbursements to certain outpatient providers
§ 1906. Recoupment of amounts spent on child medical care
§ 1906a. Recovery against estate; homestead exemptions
§ 1908. Medicaid; payer of last resort; release of information
§ 1908a. Vermont Partnership for Long-Term Care
§ 1909. Direct payments to Agency; discharge of insurer’s obligation
§ 1910. Liability of third parties; liens
§ 1911. Tobacco manufacturers; liability for Medicaid expenditures
§ 1918. Directory of cigarettes approved for stamping and sale
§ 1919. Prohibition against the stamping and sale of cigarettes not included in the directory
§ 1920. Agent for service of process
§ 1921. Reporting and sharing of information
§ 1922. Quarterly escrow deposits
§ 1923. Penalties and other remedies
§ 1924. Miscellaneous provisions
§ 1925. Joint and several liability of importers on nonparticipating manufacturer’s brand families
§ 1954. Nursing home assessment
§ 1955a. Home health agency assessment
§ 1956. Proceeds from assessments
§ 1959. Ambulance agency assessment
§ 1992. Medicaid coverage for adult dental services
§ 1998. Pharmacy Best Practices and Cost Control Program established
§ 1999. Consumer protection rules; prior authorization
§ 2000. Pharmacy benefit management
§ 2003. Pharmacy discount plans
§ 2004a. Evidence-Based Education and Advertising Fund
§ 2007. Canadian Prescription Drug Information Program
§ 2031. Creation of Clinical Utilization Review Board
§ 2032. Role of Department of Vermont Health Access
§ 2073. VPharm assistance program
§ 2075. Assistance in enrolling in Medicare Part D
§ 2076. Over-the-counter and generic medications
§ 2078. Education and outreach
§ 2080. Vermont Prescription Drug Pricing and Consumer Protection Program
§ 2091. Dr. Dynasaur-like coverage; legislative intent
§ 2092. Dr. Dynasaur-like coverage for certain Vermont residents